Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studies.
Al-Adwi Y, Atzeni IM, Doornbos-van der Meer B, van der Leij MJ, Varkevisser RDM, Kroesen BJ, Stel A, Timens W, Gan CT, van Goor H, Westra J, Mulder DJ. Al-Adwi Y, et al. EBioMedicine. 2023 Dec;98:104883. doi: 10.1016/j.ebiom.2023.104883. Epub 2023 Nov 22. EBioMedicine. 2023. PMID: 37995465 Free PMC article.
Self-Reported Systemic Sclerosis-Related Symptoms Are More Prevalent in Subjects with Raynaud's Phenomenon in the Lifelines Population: Focus on Pulmonary Complications.
van de Zande SC, Abdulle AE, Al-Adwi Y, Stel A, de Leeuw K, Brouwer E, Arends S, Gan CT, van Goor H, Mulder DJ. van de Zande SC, et al. Among authors: al adwi y. Diagnostics (Basel). 2023 Jun 25;13(13):2160. doi: 10.3390/diagnostics13132160. Diagnostics (Basel). 2023. PMID: 37443554 Free PMC article.
The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis.
Atzeni IM, Al-Adwi Y, Doornbos-van der Meer B, Roozendaal C, Stel A, van Goor H, Gan CT, Dickinson M, Timens W, Smit AJ, Westra J, Mulder DJ. Atzeni IM, et al. Among authors: al adwi y. Front Immunol. 2023 Jun 20;14:1189257. doi: 10.3389/fimmu.2023.1189257. eCollection 2023. Front Immunol. 2023. PMID: 37409127 Free PMC article.
Release of High-Mobility Group Box-1 after a Raynaud's Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis Pathogenesis.
Al-Adwi Y, Atzeni IM, Doornbos-van der Meer B, Abdulle AE, van Roon AM, Stel A, van Goor H, Smit AJ, Westra J, Mulder DJ. Al-Adwi Y, et al. Antioxidants (Basel). 2023 Mar 24;12(4):794. doi: 10.3390/antiox12040794. Antioxidants (Basel). 2023. PMID: 37107169 Free PMC article.
Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver.
Daga M, de Graaf IAM, Argenziano M, Barranco ASM, Loeck M, Al-Adwi Y, Cucci MA, Caldera F, Trotta F, Barrera G, Casini A, Cavalli R, Pizzimenti S. Daga M, et al. Among authors: al adwi y. Toxicol In Vitro. 2020 Jun;65:104800. doi: 10.1016/j.tiv.2020.104800. Epub 2020 Feb 19. Toxicol In Vitro. 2020. PMID: 32084521 Free article.